annual total assets:
$2.06B+$330.21M(+19.05%)Summary
- As of today (June 22, 2025), HALO annual total assets is $2.06 billion, with the most recent change of +$330.21 million (+19.05%) on December 31, 2024.
- During the last 3 years, HALO annual total assets has risen by +$959.05 million (+86.84%).
- HALO annual total assets is now at all-time high.
Performance
HALO Total assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total assets:
$2.20B+$133.06M(+6.45%)Summary
- As of today (June 22, 2025), HALO quarterly total assets is $2.20 billion, with the most recent change of +$133.06 million (+6.45%) on March 31, 2025.
- Over the past year, HALO quarterly total assets has increased by +$355.00 million (+19.28%).
- HALO quarterly total assets is now at all-time high.
Performance
HALO quarterly total assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total assets Formula
Total Assets = Current Assets + Non-Current Assets
HALO Total assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.1% | +19.3% |
| 3 y3 years | +86.8% | +89.0% |
| 5 y5 years | +264.6% | +346.1% |
HALO Total assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +86.8% | at high | +89.0% |
| 5 y | 5-year | at high | +264.6% | at high | +346.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
HALO Total assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.20B(+6.4%) |
| Dec 2024 | $2.06B(+19.1%) | $2.06B(-2.6%) |
| Sep 2024 | - | $2.12B(+7.5%) |
| Jun 2024 | - | $1.97B(+6.9%) |
| Mar 2024 | - | $1.84B(+6.2%) |
| Dec 2023 | $1.73B(-5.9%) | $1.73B(-8.4%) |
| Sep 2023 | - | $1.89B(+4.5%) |
| Jun 2023 | - | $1.81B(+6.5%) |
| Mar 2023 | - | $1.70B(-7.7%) |
| Dec 2022 | $1.84B(+66.7%) | $1.84B(-1.2%) |
| Sep 2022 | - | $1.86B(+4.7%) |
| Jun 2022 | - | $1.78B(+53.3%) |
| Mar 2022 | - | $1.16B(+5.2%) |
| Dec 2021 | $1.10B(+90.4%) | $1.10B(-6.8%) |
| Sep 2021 | - | $1.19B(+15.6%) |
| Jun 2021 | - | $1.03B(+6.1%) |
| Mar 2021 | - | $966.58M(+66.7%) |
| Dec 2020 | $579.92M(+2.5%) | $579.92M(+10.7%) |
| Sep 2020 | - | $524.03M(-0.6%) |
| Jun 2020 | - | $527.00M(+7.0%) |
| Mar 2020 | - | $492.35M(-13.0%) |
| Dec 2019 | $565.87M(+28.5%) | $565.87M(+52.8%) |
| Sep 2019 | - | $370.36M(-11.4%) |
| Jun 2019 | - | $417.83M(-2.6%) |
| Mar 2019 | - | $429.11M(-2.5%) |
| Dec 2018 | $440.25M(-15.3%) | $440.25M(-1.0%) |
| Sep 2018 | - | $444.51M(-6.4%) |
| Jun 2018 | - | $474.75M(-4.2%) |
| Mar 2018 | - | $495.47M(-4.7%) |
| Dec 2017 | $519.95M(+98.8%) | $519.95M(+45.6%) |
| Sep 2017 | - | $357.15M(+3.6%) |
| Jun 2017 | - | $344.79M(+52.0%) |
| Mar 2017 | - | $226.77M(-13.3%) |
| Dec 2016 | $261.51M(+43.9%) | $261.51M(-7.4%) |
| Sep 2016 | - | $282.50M(-4.6%) |
| Jun 2016 | - | $296.13M(-4.2%) |
| Mar 2016 | - | $309.10M(+70.0%) |
| Dec 2015 | $181.79M(+9.5%) | $181.79M(+14.5%) |
| Sep 2015 | - | $158.73M(-8.8%) |
| Jun 2015 | - | $174.05M(+9.4%) |
| Mar 2015 | - | $159.13M(-4.1%) |
| Dec 2014 | $165.98M(+63.1%) | $165.98M(+0.8%) |
| Sep 2014 | - | $164.63M(-9.6%) |
| Jun 2014 | - | $182.05M(-7.9%) |
| Mar 2014 | - | $197.69M(+94.2%) |
| Dec 2013 | $101.79M | $101.79M(-7.6%) |
| Sep 2013 | - | $110.15M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $107.39M(-8.1%) |
| Mar 2013 | - | $116.87M(-13.3%) |
| Dec 2012 | $134.73M(+104.9%) | $134.73M(+24.8%) |
| Sep 2012 | - | $107.98M(-11.3%) |
| Jun 2012 | - | $121.75M(-9.6%) |
| Mar 2012 | - | $134.72M(+104.9%) |
| Dec 2011 | $65.76M(-28.0%) | $65.76M(-16.0%) |
| Sep 2011 | - | $78.24M(-12.6%) |
| Jun 2011 | - | $89.51M(+10.6%) |
| Mar 2011 | - | $80.93M(-11.4%) |
| Dec 2010 | $91.35M(+18.4%) | $91.35M(-9.0%) |
| Sep 2010 | - | $100.39M(+95.0%) |
| Jun 2010 | - | $51.49M(-21.0%) |
| Mar 2010 | - | $65.16M(-15.5%) |
| Dec 2009 | $77.15M(+0.8%) | $77.15M(-10.4%) |
| Sep 2009 | - | $86.11M(-10.6%) |
| Jun 2009 | - | $96.30M(+39.7%) |
| Mar 2009 | - | $68.93M(-10.0%) |
| Dec 2008 | $76.56M(-26.0%) | $76.56M(-5.2%) |
| Sep 2008 | - | $80.75M(-8.8%) |
| Jun 2008 | - | $88.56M(-10.4%) |
| Mar 2008 | - | $98.87M(-4.4%) |
| Dec 2007 | $103.46M(+124.5%) | $103.46M(-5.9%) |
| Sep 2007 | - | $109.99M(+5.6%) |
| Jun 2007 | - | $104.13M(+41.0%) |
| Mar 2007 | - | $73.87M(+60.3%) |
| Dec 2006 | $46.09M(+124.7%) | $46.09M(+158.8%) |
| Sep 2006 | - | $17.81M(+5.8%) |
| Jun 2006 | - | $16.84M(-11.2%) |
| Mar 2006 | - | $18.97M(-7.5%) |
| Dec 2005 | $20.51M(+25.0%) | $20.51M(+177.7%) |
| Sep 2005 | - | $7.39M(-32.5%) |
| Jun 2005 | - | $10.94M(-21.2%) |
| Mar 2005 | - | $13.88M(-15.4%) |
| Dec 2004 | $16.40M(+2434.6%) | $16.40M(+333.4%) |
| Sep 2004 | - | $3.79M(-39.0%) |
| Jun 2004 | - | $6.21M(-19.7%) |
| Mar 2004 | - | $7.73M(+1094.8%) |
| Dec 2003 | $647.20K(+180.7%) | $647.20K(+850.4%) |
| Sep 2003 | - | $68.10K(-11.6%) |
| Jun 2003 | - | $77.00K(-16.3%) |
| Mar 2003 | - | $92.00K(-60.1%) |
| Dec 2002 | $230.60K(+783.5%) | $230.60K(+68.6%) |
| Sep 2002 | - | $136.80K(-7.3%) |
| Jun 2002 | - | $147.50K(+289.2%) |
| Mar 2002 | - | $37.90K |
| Dec 2001 | $26.10K | - |
FAQ
- What is Halozyme Therapeutics annual total assets?
- What is the all time high annual total assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual total assets year-on-year change?
- What is Halozyme Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly total assets year-on-year change?
What is Halozyme Therapeutics annual total assets?
The current annual total assets of HALO is $2.06B
What is the all time high annual total assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual total assets is $2.06B
What is Halozyme Therapeutics annual total assets year-on-year change?
Over the past year, HALO annual total assets has changed by +$330.21M (+19.05%)
What is Halozyme Therapeutics quarterly total assets?
The current quarterly total assets of HALO is $2.20B
What is the all time high quarterly total assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly total assets is $2.20B
What is Halozyme Therapeutics quarterly total assets year-on-year change?
Over the past year, HALO quarterly total assets has changed by +$355.00M (+19.28%)